Randomized, Double-Blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine.

Trial Profile

Randomized, Double-Blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2014

At a glance

  • Drugs West Nile virus vaccine (Primary)
  • Indications West Nile virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 01 Jan 2011 Results were published in the Journal of Infectious Diseases (part 2).
    • 01 Jan 2011 Results were published in the Journal of Infectious Diseases (part 1).
    • 14 Apr 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top